As many as 150 students of three government residential schools located within one campus in Gujarat's Surat district suffered from a viral infection and 18 of them, all girls, were hospitalised with ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or inhalation. A nasal COVID-19 vaccine, developed using technology from Washington ...
"It is a common virus that causes upper respiratory tract infections, and its infections are characterized by self-limiting illnesses," the spokesman said at a daily news conference when asked about ...
Long-term exposure to PM2.5, PM10, NO2 and ozone (O3) air pollution is associated with more hospital admissions for lower respiratory tract infections in adults.
As if colds, influenza and other respiratory infections weren’t enough to make Minnesotans ill in winter, this is also the time of year when digestive tract illness caused by a family of ...
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...
A new scoping review examines the impact of respiratory bacteria on the severity of respiratory syncytial virus (RSV) ...
Six dairy herds in Nevada have tested positive for a newer variant of the H5N1 bird flu virus that’s been associated with ...
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
especially in the nose and respiratory tract. In animal studies conducted in 2020 and 2021, the nasal vaccine entirely prevented infection from taking hold in the nose and lungs — suggesting that ...
Air pollution is a well-known risk factor for respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD).
Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.